SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology
HOLLAND, Mich., August 9th, 2021—Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, SpinTech, has received FDA 510(k) clearance for their STAGE™ magnetic resonance imaging software. SpinTech is a privately-held medical device company at the frontier […]
SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology Read More »